Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gehrig

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Gastroenterology|August 12, 2009
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activationMenashe Elazar, Michael Liu, Sean A McKenna, et al.
Plos One|February 15, 2013
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cellsChunxiao Zhou, Tara A Steplowski, Hallum K Dickens, et al.
Cancer Medicine|November 25, 2014
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancerKevin M Schuler, Brooke S Rambally, Megan J DiFurio, et al.
Gynecologic Oncology|April 4, 2017
Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survivalEmma L Barber, Stacie B Dusetzina, Karyn B Stitzenberg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologistsAngeles Alvarez Secord, Victoria Bae-Jump, Laura J Havrilesky, et al.
Gynecologic Oncology|November 3, 2015
Body mass index and mortality in endometrial cancer: A systematic review and meta-analysisAngeles Alvarez Secord, Vic Hasselblad, Vivian E Von Gruenigen, et al.
Human Genetics|March 10, 1999
Mapping and genomic characterization of the gene encoding diacylglycerol kinase gamma (DAGK3): assessment of its role in dominant optic atrophy (OPA1)H Stöhr, J Klein, A Gehrig, et al.
Cancer|September 29, 2004
Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?David M Boruta, Paola A Gehrig, Pamela A Groben, et al.
American Journal of Clinical Oncology|December 18, 2018
Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile NeutropeniaCamille C Gunderson, Britt K Erickson, Ivy Wilkinson-Ryan, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Gastroenterology|August 12, 2009
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activationMenashe Elazar, Michael Liu, Sean A McKenna, et al.
Plos One|February 15, 2013
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cellsChunxiao Zhou, Tara A Steplowski, Hallum K Dickens, et al.
Cancer Medicine|November 25, 2014
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancerKevin M Schuler, Brooke S Rambally, Megan J DiFurio, et al.
Gynecologic Oncology|April 4, 2017
Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survivalEmma L Barber, Stacie B Dusetzina, Karyn B Stitzenberg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2009
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologistsAngeles Alvarez Secord, Victoria Bae-Jump, Laura J Havrilesky, et al.
Gynecologic Oncology|November 3, 2015
Body mass index and mortality in endometrial cancer: A systematic review and meta-analysisAngeles Alvarez Secord, Vic Hasselblad, Vivian E Von Gruenigen, et al.
Human Genetics|March 10, 1999
Mapping and genomic characterization of the gene encoding diacylglycerol kinase gamma (DAGK3): assessment of its role in dominant optic atrophy (OPA1)H Stöhr, J Klein, A Gehrig, et al.
Cancer|September 29, 2004
Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?David M Boruta, Paola A Gehrig, Pamela A Groben, et al.
American Journal of Clinical Oncology|December 18, 2018
Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile NeutropeniaCamille C Gunderson, Britt K Erickson, Ivy Wilkinson-Ryan, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Pageof 20